1. Publication
- Title: A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The LIBERATE-D Randomized Clinical Trial
- Acronym: LIBERATE-D
- Year & Journal: JAMA, epublished November 7, 2025 (print: 2026;335(4):326-335)
- Citation: Liu KD, Siew ED, Tuot DS, et al. JAMA. 2026;335(4):326-335. doi:10.1001/jama.2025.21530
2. Context & Rationale
Background: AKI-D survivors face substantial risk of death, prolonged hospitalization, and persistent dialysis dependence. Prior evidence (STARRT-AKI, AKIKI 2) showed early dialysis initiation does not benefit patients; whether a similarly conservative approach benefits dialysis liberation timing was untested.
Research Question/Hypothesis: In hemodynamically stable AKI-D adults, does an indication-triggered conservative dialysis strategy increase kidney function recovery at discharge vs conventional thrice-weekly dialysis?
Why This Matters: Extends the "less is sometimes more" dialysis-timing paradigm from initiation to the liberation/discontinuation phase.
3. Design & Methods
- Study Type: Multicenter, unblinded, randomized superiority trial
- Setting & Centers: 4 US sites
- Population: Hemodynamically stable AKI-D adults, ≥1 day prior CRRT/HD, baseline eGFR ≥15, expected to need outpatient dialysis. Mean age 56y, 67% male, 80% ICU prior to randomization.
- Intervention: Conservative dialysis — hemodialysis only when prespecified metabolic/clinical indications met (n=109)
- Comparator: Conventional thrice-weekly dialysis (n=109-111)
- Randomization: 1:1, 220 patients
- Blinding: Unblinded
- Statistical Power & Follow-Up: Powered to detect 20% absolute increase in recovery. Primary outcome: kidney recovery at discharge (alive, off dialysis ≥14 days). Not stopped early.
4. Key Results
Outcome | Conservative | Conventional | Effect Size | 95% CI | p-value | Notes |
Kidney recovery at discharge (primary) | 70/109 (64%) | 55/109 (50%) | Diff 13.8pp | 0.8–26.8 | 0.04 | Significant |
Dialysis sessions/week, dialysis-free days | Fewer/more | — | — | — | — | Reduced burden |
Dialysis-associated hypotension | Fewer events | — | — | — | — | Safety signal favors conservative |
Recovery at day 28/90 | Converged | Converged | — | — | — | Early advantage did not persist as between-group difference |
5. Internal Validity Assessment
- Randomization & Allocation: 1:1 across 4 sites, well-balanced baseline characteristics per independent review.
- Protocol Adherence & Separation: Clear prespecified trigger criteria for conservative arm.
- Blinding & Detection Bias: Unblinded — real limitation, though primary outcome relatively objective.
- Overall Internal Validity Conclusion: Moderate-to-strong — adequately powered, statistically significant, but wide CI and convergence of recovery rates by day 90 (per independent NephJC review) suggest the discharge-timepoint benefit reflects accelerated rather than net-additional recovery.
6. External Validity Assessment
- Population Representativeness: Well-defined, hemodynamically stable transitional AKI-D population; excludes unstable ICU patients on CRRT.
- Overall External Validity Conclusion: Good for stable AKI-D patients transitioning toward liberation; less informative for unstable CRRT patients.
7. Strengths & Limitations
Strengths: Extends conservative-timing paradigm to liberation phase; adequately powered, not stopped early; consistent unadjusted/adjusted results; additional hypotension safety signal.
Limitations: Unblinded; modest sample (220, 4 sites); recovery rates converged by day 28/90; wide CI.
8. Interpretation & Practice Impact
- Clinical Implications: Supports indication-triggered dialysis over routine thrice-weekly dialysis in stable AKI-D patients.
- Mechanistic Coherence: Convergence by day 90 suggests acceleration of recovery rather than prevention of dialysis dependence — still clinically valuable (earlier discharge, less burden).
- Systems-Level Takeaway: Could reduce resource use and improve patient experience via individualized, indication-based dialysis.
9. Controversies & Subsequent Evidence
Independent NephJC review specifically flags the day-28/90 convergence as an important caveat against over-interpreting long-term benefit. Extends STARRT-AKI (2020) and AKIKI 2 (2021) evidence to the liberation phase.
10. Summary & Executive Takeaway
Summary: LIBERATE-D randomized 220 stable AKI-D adults to conservative or conventional dialysis. Kidney recovery at discharge was higher with conservative strategy (64% vs 50%, P=0.04), with fewer sessions and hypotension events, though recovery rates converged by day 90.
Overall Takeaway: Indication-triggered dialysis accelerates recovery and reduces burden/hypotension vs routine thrice-weekly dialysis in stable AKI-D patients — understood as accelerating recovery and reducing resource use rather than preventing long-term dialysis dependence.
11. Bibliography
- STARRT-AKI Investigators. N Engl J Med. 2020;383(3):240-251.
- Gaudry S, et al. AKIKI 2. Lancet. 2021;397(10281):1293-1300.